Chronic Disease Management Market

Chronic Disease Management Market Size and Share:

The global chronic disease management market size was valued at USD 6.5 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 14.8 Billion by 2033, exhibiting a CAGR of 9.55% from 2025-2033. North America currently dominates the market. The surging prevalence of chronic diseases, rising awareness about mobile health (m-health), and the growing adoption of wearable devices represent some of the key factors driving the market.

The industry is driven by numerous trends and factors that reflect the evolving healthcare landscape. Among the major drivers of the market, increasing global prevalence of chronic diseases like hypertension, diabetes, heart disease, cancer, respiratory disorders stands out. The reasons for the rise in chronic diseases are multifaceted, ranging from an aging population to unhealthy lifestyle choices, sedentary behavior, poor diet, and environmental factors. As the population of the world ages, the demand for chronic disease management (CDM) solutions is increasing. This makes it a very sensitive area where healthcare systems worldwide urgently need attention.

The United States has emerged as a major region in the CDM market owing to many reasons. The increasing global prevalence of chronic diseases, such as diabetes, hypertension, heart disease, respiratory disorders, and cancer, is one of the primary drivers of the market. Factors responsible for an increase in chronic diseases are related to lifestyle factors, such as poor lifestyle, unhealthy lifestyles, sedentary behavior, bad diets, and environmental causes. An ageing global population calls for increasing demands on healthcare systems in finding effective solutions for CDMs. In response, the health providers have begun to create and implement various plans aimed at better patient care, better outcome, and the lowering of health costs of chronic diseases. Changes from the conventional reactive health system towards proactive preventive, and person-centered care lead to the incorporation of digital health technologies, telemedicine, wearable devices, and mobile health applications. This facilitates remote health monitoring of the patients, follow up on the progress of the disease symptoms, medications, and potential complications' onset. The IMARC group projected that in terms of CAGR, during the period from 2024-2032, the market is expected to experience a 12.70% growth in the US.

Chronic Disease Management Market Trends:

Advancements in Digital Health Technologies

Digital health technologies are changing the dynamics of the market. Ever-evolving technologies from telemedicine to remote monitoring devices, wearable health trackers, and mobile health applications empower people with chronic conditions to take more control of their health status, providing healthcare providers with real-time data regarding the condition of their patients. Remote monitoring solutions enable patients to monitor their blood glucose levels, blood pressure, heart rate, and oxygen saturation, while wearables have extended functionalities like electrocardiogram monitoring, activity tracking, and sleep analysis. Such technologies present a more proactive approach to the management of disease because health providers can intervene at the earliest opportunity when the patient begins to worsen, preventing complications and decreasing readmissions in hospitals. In 2024, AliveCor declared the FDA’s clearance and introduction of its AI for ECG interpretation and streamlined.

Rising Prevalence of Chronic Diseases

One of the major drivers for the market is the growing prevalence of chronic diseases. Diabetes, heart disease, hypertension, obesity, and chronic respiratory diseases have become a major health issue worldwide, particularly in developed countries. According to the Centers for Disease Control and Prevention (CDC), around six in ten adults in the United States suffer from a chronic disease, while four in ten are diagnosed with two or more conditions. Most are attributed to increasing age, inappropriate lifestyle habits, poor diets, lack of exercises, and exposures to unhealthy environment. With aging, individuals are more prone to chronic conditions, most of which are lifelong and have lasting management requirement. The aged population significantly contributes to the trend since older adults have a likelihood of developing multiple chronic conditions, thus creating a greater demand for effective management solutions. The economic burden of managing chronic diseases is high, and therefore healthcare systems have come to focus on improving disease management practices in terms of quality of life, reducing hospital admissions, and managing healthcare costs. In response to this, healthcare providers are investing in CDM programs focused on preventive care, early intervention, and personalized treatment plans.

Shift Toward Value-Based Healthcare Models

The shift towards value-based healthcare models is supporting the growth of the market. In contrast to the traditional fee-for-service models, where healthcare providers are paid as per the volume of services rendered, value-based care focuses on improving patient outcomes while reducing overall healthcare costs. This incentive drives providers of health services to concentrate on prevention, early intervention, and chronic disease management to avoid unnecessary and costly hospitalizations and trips to the emergency room. CDM is a part of value-based healthcare because it proactively manages conditions such as diabetes, heart diseases, and hypertension, thus preventing complications and related costs in the long run. This shift is crucially supported by the government and other insurance companies through reimbursement for services such as remote monitoring and care coordination related to CDM. For example, in 2024, Protective Life Corporation announced a new rider for the company's flagship Protective Classic Choice term policy. Such a new initiative will offer comprehensive coverage and better protection and chronic ailments coverage.

Chronic Disease Management Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global chronic disease management market, along with forecast at the global, regional, and country levels from 2025-2033. The market has been categorized based on type, disease type, deployment type, and end user.

Analysis by Type:

• Solutions
• Services

Solutions constitute the largest segment, including a diverse array of technological products and tools created to assist in managing and treating chronic conditions. These solutions encompass software platforms, remote monitoring tools, telemedicine apps, wearable health monitors, and mobile health applications that assist healthcare providers in offering ongoing care to patients beyond conventional clinical environments. They facilitate live tracking of essential indicators like glucose levels, blood pressure, oxygen saturation and heart rate, permitting timely interventions when needed. Additionally, artificial intelligence (AI) and machine learning (ML) are commonly incorporated into these solutions to improve decision-making, tailor treatment plans, and forecast disease progression. Digital health solutions provide various benefits, including enhancing patient involvement, boosting compliance with prescribed therapies, lowering hospital readmissions, and enabling prompt interventions, thereby decreasing overall healthcare expenses.

Analysis by Disease Type:

• Cardiovascular Diseases
• Diabetes
• Cancer
• Asthma
• Chronic Obstructive Pulmonary Disorders
• Others

Diabetes constitutes the largest segment due to the rising worldwide prevalence of the disease and its considerable effect on public health. Diabetes, especially Type 2 diabetes, significantly contributes to the increasing prevalence of chronic diseases globally, worsened by lifestyle elements like unhealthy eating, insufficient exercise, and obesity. Proper management of diabetes is essential to prevent complications like cardiovascular disease, kidney failure, blindness, and nerve damage, which can lead to significant healthcare expenses. The increasing incidence of diabetes has caused a rise in the need for diabetes management solutions, such as blood glucose monitors, insulin delivery systems, mobile health applications, telehealth services, and digital therapy options. These technologies assist patients in controlling their blood sugar levels, monitoring symptoms, and obtaining prompt interventions from healthcare professionals, enhancing overall health outcomes.

Analysis by Deployment Type:

• On-premises
• Cloud-based
• Web-based

On-premises account for the majority of the market share as they benefit the organizations with their security, control, and customization benefits. Solutions on-premises are held within the health provider's infrastructure; thus, the organization gets to retain control over all the data and measures taken for security. This aspect is especially vital for health care institutions, given their stringent requirement for adhering to data privacy regulations. The sensitive patient information is safe in the hands of healthcare providers by keeping the infrastructure of software and hardware in-house, as they do not need to be transferred over the internet or stored in third-party servers. On-premises systems are highly customizable, enabling health care organizations to tailor CDM solutions to the specific needs of their workflow, patient population, and more. This level of control and customization is particularly important to large hospitals, health systems, and clinics which have complex needs and want a greater degree of governance over their CDM platforms.

Analysis by End User:

• Healthcare Providers
• Healthcare Payers
• Others

Healthcare providers hold the biggest market share. These organizations are responsible for reimbursing healthcare providers for the services and treatments provided to patients with chronic conditions. With the increasing burden of chronic diseases and the associated rising healthcare costs, healthcare payers are increasingly incentivized to support preventive care and efficient management of chronic conditions. By promoting early intervention, reducing hospital admissions, and managing long-term care, healthcare payers aim to lower overall healthcare expenditures. As such, insurance companies and government payers are investing in CDM programs that emphasize care coordination, disease prevention, and remote monitoring. These programs often include reimbursement for services such as telemedicine consultations, home health services, and digital health tools that assist in disease management. Healthcare payers are also leveraging data analytics and predictive models to identify high-risk patients and implement targeted interventions.

Regional Analysis:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
• Others Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America represents the largest segment because of several key trends and factors, most notably the increasing prevalence of chronic diseases, enhancements in digital health technologies, and the shift toward value-based healthcare models. Chronic diseases, such as diabetes, cardiovascular diseases, hypertension, asthma, and chronic obstructive pulmonary disease (COPD), have become major health concerns in North America, particularly in the United States, where nearly six in ten adults live with at least one chronic condition. The aging population is a primary driver behind this surge, as older individuals are more susceptible to chronic diseases, with multi-morbidity becoming increasingly common. Alongside aging, lifestyle factors such as poor diet, physical inactivity, smoking, and high levels of stress have significantly contributed to the rise in chronic diseases across the region. These conditions place immense pressure on healthcare systems, leading to higher healthcare costs, hospitalizations, and long-term care requirements, which in turn necessitate more effective and sustainable chronic disease management solutions. As healthcare providers, payers, and patients seek to reduce the economic and health burdens associated with chronic diseases, the demand for CDM services and solutions has risen rapidly in North America. In 2024, Lirio announced the launch of a second intervention based on diabetes with Cone Health. This partnership focuses on Cone Health’s plans to improve chronic condition management and patient experience in North Carolina.

Key Regional Takeaways:

United States Chronic Disease Management Market Analysis

The expanding focus on healthcare infrastructure has substantially increased the adoption of chronic disease management programs. For instance, U.S. healthcare companies securing venture capital deals of USD 15 Million plus are driving robust investment growth, focusing on innovation in medical technology to meet rising market demands. Investments in advanced medical systems, research, and patient-centered care have transformed how individuals access and manage long-term conditions. Enhanced diagnostic tools and personalized treatment plans have been integrated into healthcare systems to improve outcomes. The emphasis on multidisciplinary care teams, combining expertise across medical fields, facilitates comprehensive disease management. These developments, alongside policies encouraging health innovations, have elevated chronic condition monitoring and patient engagement. Examples include innovative tools for cardiovascular health and technologies aiding patient compliance. As healthcare budgets grow, resources allocated toward addressing long-term conditions ensure that chronic disease management becomes a priority. The dynamic interplay of patient education, support programs, and progressive medical practices continues to shape an environment conducive to managing chronic ailments effectively.

Europe Chronic Disease Management Market Analysis

The aging population has prompted significant advancements in chronic disease management. For instance, Europe's ageing population is on the rise, with one in five Europeans now aged 65 or older, projected to approach 30% by 2050. Older individuals often experience multiple health conditions, requiring coordinated care and continuous monitoring. Programs designed to support these needs emphasize early intervention and tailored treatments, often incorporating nutrition, rehabilitation, and ongoing assessments. Healthcare systems are investing in resources to improve accessibility for this demographic, ensuring timely check-ups and disease management consultations. Local clinics and senior health centers play a critical role in implementing these strategies, offering age-appropriate services and guidance. Additionally, initiatives focused on mobility aids, cognitive health, and chronic condition management provide a comprehensive approach to improving quality of life. Examples include specialized programs addressing cardiovascular and musculoskeletal health concerns. These efforts are reshaping the care landscape, enabling older individuals to maintain independence and proactively manage their conditions within supportive healthcare frameworks.

Asia Pacific Chronic Disease Management Market Analysis

The increasing prevalence of diabetes in the region has underscored the importance of effective chronic disease management solutions. According to National Library of Medicine, the prevalence of diabetes in India has risen from 7.1% in 2009 to 8.9% in 2019. Educational initiatives and awareness campaigns have expanded the focus on preventive measures, dietary guidance, and long-term monitoring. Digital tools for glucose tracking and innovative patient support systems are being developed to aid in disease control. Community-level programs promoting healthier lifestyles have been instrumental in early diagnosis and better disease management. Meanwhile, collaborations between healthcare providers and local authorities ensure access to resources for diabetes care. Examples include specialized clinics and programs offering guidance on disease progression and complications. Additionally, a shift toward holistic approaches integrating physical and mental well-being has driven the demand for personalized management plans. Efforts to align with evolving patient needs further amplify the adoption of strategies that cater specifically to diabetes control and its related conditions.

Latin America Chronic Disease Management Market Analysis

Private healthcare systems have become pivotal in expanding access to chronic disease management solutions. According to International Trade Administration, Brazil is the largest healthcare market in Latin America with 7,191 hospitals, 62% are private. These institutions offer specialized services tailored to long-term condition monitoring and treatment. Enhanced infrastructure and dedicated resources for patient education ensure efficient care delivery for chronic conditions. Clinics and hospitals with advanced diagnostic tools and support programs cater to evolving patient needs, focusing on personalized care pathways. Examples include initiatives targeting chronic respiratory and cardiac conditions, providing holistic support to patients. This structured approach has improved patient outcomes, with private providers consistently updating their services to include the latest advancements. As private healthcare systems grow, they play a central role in driving the adoption of comprehensive chronic disease management strategies across diverse demographics.

Middle East and Africa Chronic Disease Management Market Analysis

The development of healthcare facilities has significantly bolstered chronic disease management. According to Dubai Healthcare City Authority report, Dubai's healthcare sector saw rapid growth, with 4,482 private medical facilities and 55,208 licensed professionals by 2022, projected to expand further by 3-6% in facilities and 10-15% in professionals in 2023. New hospitals and specialized clinics are enhancing the availability of care for individuals with long-term conditions. These facilities focus on early diagnosis, effective treatment, and ongoing patient support, ensuring a robust framework for disease control. Examples include programs aimed at managing metabolic and cardiovascular disorders, which are gaining traction in response to evolving health trends. Infrastructure growth also facilitates the integration of advanced treatment techniques, safeguarding that patients are given high-quality care. These improvements create a positive outlook for the widespread adoption of chronic disease management solutions, addressing regional healthcare challenges efficiently.

Competitive Landscape:

Key players in the chronic disease management (CDM) market are taking several strategic actions to improve their businesses and expand their market share. One of the primary ways market players are improving their business is by investing in and integrating advanced digital health technologies into their offerings. Companies are increasingly adopting telemedicine solutions, remote monitoring devices, mobile health apps, and AI-driven analytics to provide more personalized, efficient, and scalable chronic disease management services. For instance, in 2024, WELL launched the WELL AI Decision Support, integrated with advanced chronic disease screening. Another important strategy is the formation of strategic partnerships and acquisitions to expand their product portfolios and extend their market reach. Companies are increasingly collaborating with healthcare providers, payers, and technology firms to create integrated solutions that support chronic disease management.

The report provides a comprehensive analysis of the competitive landscape in the chronic disease management market with detailed profiles of all major companies, including:

• Altruista Health Inc.
• Cliexa Inc
• ExlService Holdings, Inc
• Infosys Limited
• International Business Machines Corporation
• Koninklijke Philips N.V.
• Mines & Associates Inc.
• ScienceSoft USA Corporation
• TCS Healthcare Technologies
• Zeomega Inc.

Latest News and Developments:

• July 2024: HealthSnap, a virtual care management leader partnering with 150+ health systems, unveiled its 2024 Clinical Outcomes Report, showcasing Remote Patient Monitoring (RPM) and Chronic Care Management's (CCM) success in managing hypertension, obesity, and type II diabetes. The study, involving 41,940 patients with 90+ program days and 50% data transmission, revealed significant clinical outcome improvements, underscoring RPM and CCM's effectiveness in chronic disease management.
• May 2024: Loughborough researchers, in partnership with Holly Health and Modality Partnership, are developing the Prevent App to revolutionize chronic disease management. Backed by £447,000 from Innovate UK, the app employs a Just-in-Time Adaptive Intervention (JITAI) system, using machine learning to support individuals with multiple chronic conditions in better managing their health.
• January 2024: Amazon Health has unveiled "Health Condition Programs" to enhance chronic disease management, starting with partnerships like Omada Health. Customers can check insurance coverage and clinical eligibility for programs supporting conditions like diabetes and hypertension. Covered users gain access to devices, virtual health coaching, and exclusive forums.

Chronic Disease Management Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the chronic disease management market from 2019-2033.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the global chronic disease management market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's Five Forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the chronic disease management industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.